Christopher Murray
Chief Tech/Sci/R&D Officer presso BLUEPRINT MEDICINES CORPORATION
Patrimonio netto: 3 M $ in data 31/03/2024
Posizioni attive di Christopher Murray
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| BLUEPRINT MEDICINES CORPORATION | Chief Tech/Sci/R&D Officer | 10/10/2017 | - |
Storia della carriera di Christopher Murray
Precedenti posizioni note di Christopher Murray
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ARIAD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/12/2013 | 01/05/2017 |
Formazione di Christopher Murray
| Hope College | Undergraduate Degree |
| The University of Chicago | Graduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
Posizioni
| Chief Tech/Sci/R&D Officer | 1 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| BLUEPRINT MEDICINES CORPORATION | Health Technology |
| Aziende private | 1 |
|---|---|
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Christopher Murray
- Esperienza
